Regenfro Co

Developer of therapeutics to treat renal diseases

placeKyoto, Kyoto, Japan calendar_todayFounded 2019 language regenephro.co.jp

Social engagement

Social engagement: 311 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

21 investors on record; lead investors include Mitsubishi UFJ Capital, Kyoto University Innovation Capital, JAFCO Group, M3.

Investor typeCountShare
Venture capital1362%
Private equity210%
Other / undisclosed629%

Recent activity

10 Oct 2025
Event
Global Startup Expo 2025
6 Oct 2025
Partnership
Bayer Yakuhin Ltd.
Coming soon